Atlas FDA

GEM 21S (GROWTH-FACTOR ENHANCED MATRIX

FDA premarket approval P040013 · decided 2005-11-18

Approval details

PMA number
P040013
Trade name
GEM 21S (GROWTH-FACTOR ENHANCED MATRIX
Generic name
Bone grafting material, dental, with biologic component
Applicant
Lynch Biologics, LLC
Date received
2004-03-12
Decision date
2005-11-18
Days to decision
616 days
Decision code
APPR
Product code
NPZ
Advisory committee
Dental
Expedited review
No
Location
Franklin, TN
Statement
APPROVAL FOR THE GEM 21S (GROWTH-FACTOR ENHANCED MATRIX). THE DEVICE IS INDICATED TO TREAT THE FOLLOWING PERIODONTALLY RELATED DEFECTS: 1) INTRABONY PERIODONTAL DEFECTS 2) FURCATION PERIODONTAL DEFECTS 3) GINGIVAL RECESSION ASSOCIATED WITH PERIODONTAL DEFECTS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.